Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3326273
Max Phase: Preclinical
Molecular Formula: C35H56N12O14S2
Molecular Weight: 933.04
Molecule Type: Protein
Associated Items:
ID: ALA3326273
Max Phase: Preclinical
Molecular Formula: C35H56N12O14S2
Molecular Weight: 933.04
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(C)=O)CSSC[C@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O
Standard InChI: InChI=1S/C35H56N12O14S2/c1-6-14(4)27-35(61)43-18(9-24(38)51)30(56)41-16(7-22(36)49)29(55)42-17(8-23(37)50)31(57)45-20(28(39)54)11-62-63-12-21(40-15(5)48)33(59)46-26(13(2)3)34(60)44-19(10-25(52)53)32(58)47-27/h13-14,16-21,26-27H,6-12H2,1-5H3,(H2,36,49)(H2,37,50)(H2,38,51)(H2,39,54)(H,40,48)(H,41,56)(H,42,55)(H,43,61)(H,44,60)(H,45,57)(H,46,59)(H,47,58)(H,52,53)/t14-,16-,17-,18-,19-,20+,21-,26-,27-/m0/s1
Standard InChI Key: VXFIYXDXPBZJRN-VNDFSXJLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 933.04 | Molecular Weight (Monoisotopic): 932.3480 | AlogP: -6.43 | #Rotatable Bonds: 13 |
Polar Surface Area: 442.46 | Molecular Species: ZWITTERION | HBA: 15 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.19 | CX Basic pKa: 19.66 | CX LogP: -8.31 | CX LogD: -11.34 |
Aromatic Rings: 0 | Heavy Atoms: 63 | QED Weighted: 0.08 | Np Likeness Score: 0.71 |
1. Yap BK, Leung EW, Yagi H, Galea CA, Chhabra S, Chalmers DK, Nicholson SE, Thompson PE, Norton RS.. (2014) A potent cyclic peptide targeting SPSB2 protein as a potential anti-infective agent., 57 (16): [PMID:25068993] [10.1021/jm500596j] |
Source(1):